Why Shares of Orchestra BioMed Jumped Tuesday
The company got approval from the FDA to go ahead with a pivotal study for a hypertension therapy.
Why Shares of Orchestra BioMed Holdings Jumped Wednesday
The stock bounced back from hitting an all-time low the day before.
3 Stocks That Already Doubled in 2023 and Could Keep Climbing
The gains these stocks notched in the first few months of the year could be the beginning of a much longer bull run.
Why Shares of Orchestra BioMed Jumped This Week
The company is considered one of the top medical device start-ups this year.
Vivasure Medical Announces FDA IDE Approval to Initiate U.S. Pivotal Study
Vivasure Medical ® Limited (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the U.S. Food and Drug...